Europe Incontinence Devices And Ostomy Market Size and Share

Europe Incontinence Devices And Ostomy Market (2026 - 2031)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Europe Incontinence Devices And Ostomy Market Analysis by Mordor Intelligence

The Europe Incontinence Devices And Ostomy Market size was valued at USD 17.89 billion in 2025 and is estimated to grow from USD 18.71 billion in 2026 to reach USD 23.42 billion by 2031, at a CAGR of 5.58% during the forecast period (2026-2031).

Adoption accelerates as Western Europe’s public insurers reimburse most long-term continence supplies, prompting hospitals and home-care providers to standardize procurement through multi-year tenders. Vendors intensify focus on disposable pads, intermittent catheters, and ostomy bags that shorten inpatient stays and prevent pressure injuries, helping health systems curb nursing hours and readmissions. Meanwhile, digital pelvic-floor stimulators and connected ostomy pouches feed real-time data into tele-urology platforms, giving clinicians remote visibility of stoma output, leakage events, and catheter dwell times. Sustainability mandates under the EU circular-economy plan push manufacturers to integrate biodegradable non-wovens, mono-material film barriers, and post-consumer recycled plastics across their product lines. 

Key Report Takeaways

  • By product type, incontinence care products led the Europe incontinence devices and ostomy market with 66.56% market share in 2025, while disposable pads and catheters are forecast to expand at an 8.80% CAGR through 2031. 
  • By application, colorectal cancer accounted for a 34.55% share of the Europe incontinence devices and ostomy market size in 2025 and is advancing at a 7.20% CAGR through 2031. 
  • By end-user, hospitals accounted for 41.56% in 2025; home care settings are poised for a 5.84% CAGR from 2026 to 2031. 
  • By distribution channel, institutional tender procurement dominated with 45.45% in 2025, while online pharmacies and subscription services are projected to grow at an 8.03% CAGR through 2031. 
  • By technology, disposable products commanded 68.56% in 2025; smart or connected continence and ostomy devices are set to post a 9.11% CAGR during 2026-2031. 
  • By region, Germany held 22.33% in 2025, whereas the United Kingdom is on track for the fastest 5.69% CAGR over the forecast horizon. 

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.

Segment Analysis

By Product Type: Incontinence Care Dominates Revenue Mix

In 2025, incontinence care products captured 66.56% of the Europe incontinence devices and ostomy market, supported by large-volume contracts for adult diapers, pads, and intermittent catheters in public hospitals. The prevalence of urge and overflow incontinence among seniors drives procurement toward absorbent underpads that meet EU tensile-strength and biodegradability criteria. Manufacturers leverage plant-based fluff pulp and SAP blends to meet eco-label thresholds without compromising absorbency. The Europe incontinence devices and ostomy market size for disposable pads is now forecast to grow at an 8.80% CAGR through 2031 as aging households and nursing homes prioritize leak-proof nightwear. 

Ostomy care products, while smaller in share, exhibit premium ASPs thanks to convexity technology and charcoal-infused filters that curb odor. Two-piece drainable systems are gaining favor among high-output ileostomy patients because barrier rings can prolong wear time up to 7 days. Skin-friendly hydrocolloid wafers with ceramide additives reduce peristomal dermatitis incidence by 21%, boosting switching momentum away from legacy PVC pouches. Vendors invest in pediatric pouches with cartoon imagery, a fast-growing micro-segment as survivorship improves in childhood Hirschsprung disease. 

Europe Incontinence Devices And Ostomy Market: Market Share by Product Type
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Application: Colorectal Cancer Drives Ostomy Demand

Colorectal cancer surgeries accounted for 34.55% of regional revenue in 2025, and the Europe incontinence devices and ostomy market size associated with these procedures is slated for a 7.20% CAGR during 2026-2031. Enhanced screening uptake via FIT tests boosts early detection, yet surgery rates remain high, sustaining stoma creation volumes. Fast-track recovery protocols mandate low-profile silicone baseplates, accelerating pull-through of one-piece bags. 

Spinal cord injury and neurogenic bladder segments record steady growth as urban mobility accidents persist. Urostomy pouches with anti-reflux valves prevent ascending infections in paraplegic patients. Benign prostatic hyperplasia cases treated via trans-urethral resection continue to prescribe indwelling Foley catheters post-operatively, although intermittent self-catheterization programs lower infection risk and cut inpatient stay lengths. 

By End-User: Hospitals Anchor Procurement but Home-Care Rises

Hospitals accounted for 41.56% of sales in 2025, as they remain the primary dispensing point for post-surgical stoma kits and high-value neuromodulation implants. Centralized purchasing grants them volume rebates of up to 18%. However, the home-care setting is forecast to grow at a 5.84% CAGR as community nurses train ostomates in self-care protocols and families subscribe to doorstep delivery plans to avoid pharmacy queues. 

Long-term care and nursing homes are shifting toward high-capacity overnight diapers to reduce linen changes and staff workload. To improve dignity, facilities adopt odor-control polymers and breathable back-sheets that reduce pressure injuries. Smart sensor clips that notify caregivers via Wi-Fi when saturation exceeds 80% been successfully piloted in Dutch eldercare chains, signaling future up-scaling. 

Europe Incontinence Devices And Ostomy Market: Market Share by End-User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Distribution Channel: Institutional Tenders Dominate, E-Commerce Surges

Institutional tender procurement represented 45.45% of sales in 2025, reflecting Europe’s publicly funded health systems. National tenders typically bundle pads, catheters, and auxiliary cleaning wipes under a three-year framework, locking in price ceilings. Local distributors team with global OEMs to satisfy language-specific labeling and overnight delivery terms. 

Online pharmacies and subscription services are set to grow at an 8.03% CAGR through 2031. Chronic users value discrete monthly shipments and app-based reorder reminders. Vendors partner with payment platforms to offer pay-as-you-go plans, widening access for cash-strapped households. E-commerce also boosts the availability of stoma-friendly clothing and neoprene swim covers, cross-selling adjacent accessories that enrich basket size within the European incontinence devices and ostomy market. 

By Technology/System: Disposable Lines Prevail, Smart Devices Accelerate

Disposable offerings accounted for 68.56% in 2025, driven by infection-control policies and caregiver convenience. Manufacturers redesign diaper cores to use 30% recycled fluff without compromising tensile strength, aligning with the EU plastic tax. However, smart and connected continence and ostomy devices are expected to post a 9.11% CAGR. Embedded pH sensors detect alkaline shifts that precede urinary tract infections, alerting users before symptom onset. Data-driven insights lower emergency visits, building a cost-saving case for payers to sponsor device upgrades. 

Reusable garment shells with removable absorbent liners gain traction among eco-conscious millennials managing post-partum incontinence. RFID-tagged catheter packaging aids hospital stock tracking, minimizing expired inventory and easing EU MDR traceability requirements. 

Europe Incontinence Devices And Ostomy Market: Market Share by TechnologySystem
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

Geography Analysis

Germany, holding 22.33% of regional value in 2025, benefits from compulsory insurance that reimburses high-elasticity catheter sets and hydrocolloid wafers. Domestic players such as B. Braun leverage local manufacturing to avoid import duties, while university hospitals in Berlin trial next-generation sacral neuromodulation devices that deliver closed-loop nerve stimulation. Government funding for digital health apps allows prescription of continence management software, nurturing integrated care pathways. 

The United Kingdom is poised for the fastest 5.69% CAGR, as NHS supply chain frameworks endorse eco-certified diapers with at least 50% renewable content. Post—Brexit regulatory alignment through the UKCA mark streamlines market entry for U.S. catheter brands, intensifying competition. Community pharmacies expand stoma care advisory desks, and Clinical Commissioning Groups reimburse tele-urology consultations, amplifying adoption of connected pouches. 

Southern Europe lags the regional average because Spain and Italy face fragmented reimbursement systems. Nonetheless, an aging population and rising obesity are driving volume growth, especially in Catalonia’s public eldercare network. National Recovery and Resilience Plans unlock EU funds for nursing home modernization, including sensor-equipped pads that can integrate with central monitoring dashboards. The Rest of Europe bloc, covering Central and Eastern nations, is witnessing a gradual transition from gauze and cotton cloth to modern disposable briefs, with NGOs donating starter kits to improve dignity for low-income ostomates. 

Competitive Landscape

Multinationals such as Coloplast, ConvaTec, and Hollister dominate ostomy bags and skin barriers, together controlling close to half of the segment revenue. Coloplast’s SenSura Mio portfolio integrates elastic adhesive technology that conforms to hernia bulges, tightening user loyalty. ConvaTec invests in moldable seals that can be reshaped multiple times without losing tack, enhancing first-time fit for irregular body profiles. 

In incontinence care, Essity’s TENA and Kimberly-Clark’s Depend lines enjoy strong brand recognition and direct-to-consumer marketing budgets that outpace those of regional peers. Essity pilots carbon-negative diaper cores made with forest-residue-based SAP at its Swedish R&D hub, pledging a 2030 net-zero footprint that aligns with hospital sustainability targets. Axonics and Medtronic compete in sacral neuromodulation, with Axonics’ rechargeable stimulator promising 15-year battery life that lessens explant surgeries. 

Local specialists such as Paul Hartmann and Salts Healthcare supply hospital-grade dressings, leveraging established procurement relationships to cross-sell ostomy accessories. Start-ups like Atlantic Therapeutics introduce wearable pelvic-floor stimulators that pair with smartphone coaching apps, broadening non-surgical management options. Supply-chain consolidation emerges as distributors Ontex and Abena form purchasing alliances to pool raw-material contracts and stabilize pricing amid volatility in fluff pulp prices. 

Europe Incontinence Devices And Ostomy Industry Leaders

  1. Kimberly-Clark Corporation

  2. Unicharm Corporation

  3. Hollister Inc.

  4. Coloplast A/S

  5. B. Braun SE

  6. *Disclaimer: Major Players sorted in no particular order
Europe Incontinence Devices and Ostomy Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • January 2026: Coloplast launched the digital Ostomy Follow-up Platform across Germany, enabling stoma nurses to schedule virtual skin checks and automatically reorder supplies.
  • November 2025: Amara Therapeutics introduced Dry Days Health, an innovative virtual clinic designed to address the needs of women managing urinary incontinence. Despite its high prevalence globally, this condition remains significantly undertreated.
  • June 2025: Medtronic received the CE mark under the EU MDR for the InterStim X rechargeable sacral neuromodulation system, which extends battery life to 15 years.

Table of Contents for Europe Incontinence Devices And Ostomy Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric and Obese Population
    • 4.2.2 Increasing Prevalence of Renal & Urological Disorders
    • 4.2.3 Higher Incidence of Colorectal & Bladder Cancer
    • 4.2.4 Strong Reimbursement for Chronic Care in Western Europe
    • 4.2.5 Shift Toward Tele-Urology & Remote Continence Monitoring
    • 4.2.6 EU Circular Economy Pressure Spurring Eco-Friendly Disposables
  • 4.3 Market Restraints
    • 4.3.1 Complications & Peristomal Skin Issues with Long-Term Use
    • 4.3.2 Reimbursement Gaps in Eastern & Southern Europe
    • 4.3.3 High Lifetime Cost of Advanced Ostomy Supplies
    • 4.3.4 MDR Post-Market Surveillance Raising Compliance Costs
  • 4.4 Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porters Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product Type
    • 5.1.1 Incontinence Care Products
    • 5.1.1.1 Absorbent Pads & Underpads
    • 5.1.1.2 Intermittent Catheters
    • 5.1.1.3 Incontince Bags
    • 5.1.1.4 Pelvic-Floor Stimulation & Neuromodulation Devices
    • 5.1.2 Ostomy Care Products
    • 5.1.2.1 Ostomy Bags
    • 5.1.2.1.1 One-piece Systems
    • 5.1.2.1.2 Two-piece Systems
    • 5.1.2.1.3 Drainable vs Closed-end
    • 5.1.2.1.4 High-output & Pediatric Pouches
    • 5.1.2.2 Skin Barriers & Seals
    • 5.1.2.3 Irrigation & Accessories
    • 5.1.2.4 Others
  • 5.2 By Application
    • 5.2.1 Bladder Cancer
    • 5.2.2 Colorectal Cancer
    • 5.2.3 Crohns & Ulcerative Colitis
    • 5.2.4 Benign Prostatic Hyperplasia / Post-Prostatectomy
    • 5.2.5 Spinal Cord Injury & Neurogenic Bladder
    • 5.2.6 Kidney Stone & Chronic Kidney Failure
    • 5.2.7 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Home-Care Settings
    • 5.3.4 Long-term Care & Nursing Homes
    • 5.3.5 Others
  • 5.4 By Distribution Channel
    • 5.4.1 Institutional Tender Procurement
    • 5.4.2 Retail Pharmacies
    • 5.4.3 Online Pharmacies & Subscription Services
  • 5.5 By Technology / System
    • 5.5.1 Disposable Products
    • 5.5.2 Reusable / Eco-friendly Products
    • 5.5.3 Smart / Connected Continence & Ostomy Devices
  • 5.6 By Region
    • 5.6.1 Germany
    • 5.6.2 United Kingdom
    • 5.6.3 France
    • 5.6.4 Italy
    • 5.6.5 Spain
    • 5.6.6 Rest of Europe

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Abena A/S
    • 6.3.2 ALCARE Co. Ltd
    • 6.3.3 Atlantic Therapeutics Group
    • 6.3.4 Attindas Hygiene Partners
    • 6.3.5 Axonics Inc.
    • 6.3.6 B. Braun SE
    • 6.3.7 Becton Dickinson & Co. (BD)
    • 6.3.8 Boston Scientific Corporation
    • 6.3.9 Coloplast A/S
    • 6.3.10 ConvaTec Group Plc
    • 6.3.11 Essity AB (TENA)
    • 6.3.12 Hollister Incorporated
    • 6.3.13 Johnson & Johnson Services, Inc. (Ethicon)
    • 6.3.14 Kimberly-Clark Corporation
    • 6.3.15 Marlen Manufacturing & Development
    • 6.3.16 Medtronic plc
    • 6.3.17 Ontex Group NV
    • 6.3.18 Paul Hartmann AG
    • 6.3.19 Salts Healthcare Ltd
    • 6.3.20 Teleflex Incorporated
    • 6.3.21 Unicharm Corporation
    • 6.3.22 Welland Medical Ltd

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Incontinence Devices And Ostomy Market Report Scope

As per the scope of the report, ostomy surgery is a procedure that allows bodily waste to pass through a surgically created stoma on the abdomen. Ostomy care products, such as skin barriers and ostomy bags, provide a means to collect waste from a surgically diverted biological system. In incontinence, there is a lack of voluntary release of urine from the urinary bladder, for which several disposable incontinence products (DIPs) are manufactured by leading medical device companies. 

The Europe incontinence devices and ostomy market is segmented by product type, application, end-user, distribution channel, technology/system, and region. By product, the market is segmented into incontinence care products and ostomy care products. Incontinence care products are further segmented into absorbents, incontinence bags, and pelvic-floor stimulation & neuromodulation devices. By ostomy care products, the market is further segmented into ostomy bags, skin barriers, irrigation products, and other ostomy products. By application, the market is segmented into bladder cancer, colorectal cancer, Crohn's disease, kidney stone, chronic kidney failure, and other applications. By end user, the market is segmented into hospitals, ambulatory surgical centers, home care settings, long-term care & nursing homes, and others. By distribution channel, the market is segmented into institutional tender procurement, retail pharmacies, and online pharmacies & subscription services. By technology/system, the market is segmented into disposable products, reusable/eco-friendly products, and smart/connected continence & ostomy devices. By region, the market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. The report offers the value (in USD) for the above segments.

By Product Type
Incontinence Care ProductsAbsorbent Pads & Underpads
Intermittent Catheters
Incontince Bags
Pelvic-Floor Stimulation & Neuromodulation Devices
Ostomy Care ProductsOstomy BagsOne-piece Systems
Two-piece Systems
Drainable vs Closed-end
High-output & Pediatric Pouches
Skin Barriers & Seals
Irrigation & Accessories
Others
By Application
Bladder Cancer
Colorectal Cancer
Crohns & Ulcerative Colitis
Benign Prostatic Hyperplasia / Post-Prostatectomy
Spinal Cord Injury & Neurogenic Bladder
Kidney Stone & Chronic Kidney Failure
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Home-Care Settings
Long-term Care & Nursing Homes
Others
By Distribution Channel
Institutional Tender Procurement
Retail Pharmacies
Online Pharmacies & Subscription Services
By Technology / System
Disposable Products
Reusable / Eco-friendly Products
Smart / Connected Continence & Ostomy Devices
By Region
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
By Product TypeIncontinence Care ProductsAbsorbent Pads & Underpads
Intermittent Catheters
Incontince Bags
Pelvic-Floor Stimulation & Neuromodulation Devices
Ostomy Care ProductsOstomy BagsOne-piece Systems
Two-piece Systems
Drainable vs Closed-end
High-output & Pediatric Pouches
Skin Barriers & Seals
Irrigation & Accessories
Others
By ApplicationBladder Cancer
Colorectal Cancer
Crohns & Ulcerative Colitis
Benign Prostatic Hyperplasia / Post-Prostatectomy
Spinal Cord Injury & Neurogenic Bladder
Kidney Stone & Chronic Kidney Failure
Others
By End-UserHospitals
Ambulatory Surgical Centers
Home-Care Settings
Long-term Care & Nursing Homes
Others
By Distribution ChannelInstitutional Tender Procurement
Retail Pharmacies
Online Pharmacies & Subscription Services
By Technology / SystemDisposable Products
Reusable / Eco-friendly Products
Smart / Connected Continence & Ostomy Devices
By RegionGermany
United Kingdom
France
Italy
Spain
Rest of Europe
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

How large will the Europe incontinence devices and ostomy market be by 2031?

It is projected to reach USD 23.41 billion by 2031, advancing at a 5.58% CAGR from 2026.

Which product category currently leads sales?

In 2025, incontinence care products, mainly pads and catheters, accounted for 66.56% of regional revenue.

What is the fastest-growing technology segment?

Smart or connected continence and ostomy devices are forecast to grow at a 9.11% CAGR between 2026 and 2031.

Why is the United Kingdom the fastest-expanding market?

NHS adoption of eco-certified disposables and tele-urology platforms lifts demand, delivering a projected 5.69% CAGR.

How do EU sustainability rules affect suppliers?

Circular-economy directives push manufacturers toward biodegradable materials and recycling programs, shaping product redesigns and procurement criteria.

Which companies dominate the competitive landscape?

Coloplast, ConvaTec, Hollister, Essity, and Kimberly-Clark collectively control a little over 60% of regional sales.

Page last updated on:

Europe Incontinence Devices And Ostomy Market Report Snapshots